Edwin Posadas, Md
Clinical trials sponsored by Edwin Posadas, Md, explained in plain language.
-
New drug combo tested for Tough-to-Treat prostate cancer
Disease control Recruiting nowThis study is testing whether adding an experimental drug called carotuximab to an existing prostate cancer drug (apalutamide) can better control advanced prostate cancer that has stopped responding to standard hormone treatments. The trial will involve about 100 men whose cancer…
Phase: PHASE2 • Sponsor: Edwin Posadas, MD • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Early test: can new drugs prime immune system to attack prostate cancer before surgery?
Knowledge-focused Recruiting nowThis early study is testing whether giving epigenetic drugs for a few weeks before prostate removal surgery is safe and can make the tumor more visible to the patient's own immune system. It will involve about 20 men with high-risk prostate cancer who are already scheduled for su…
Phase: EARLY_PHASE1 • Sponsor: Edwin Posadas, MD • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC